Hangzhou Tigermed Consulting Co., Ltd. (03347.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

51.0x

EV/EBITDA

17.3x

Market Cap

HKD 32.45B

MomentumView details →

1D Return

−0.25%

YTD Return

−6.44%

RSI (14)

51.4

ValuationView details →

P/E (Fwd)

51.0x

EV/EBITDA

17.3x

Market Cap

HKD 32.45B

RSI (14)

51.4

MomentumView details →

1D Return

−0.25%

YTD Return

−6.44%

ProfitabilityView details →

Gross Margin

25.85%

Net Margin

1.28%

EBITDA Margin

25.14%

ROE (TTM)

0.48%

ROA (TTM)

0.33%

Asset Turnover

0.26x

GrowthView details →

Revenue YoY

+12.10%

EPS YoY

−70.59%

FCF YoY

+79.05%

Revenue CAGR 3Y

−1.20%

EPS CAGR 3Y

−23.71%

EBITDA YoY

+235.76%

EarningsView details →

EPS (Actual)

−HKD 0.63

EPS Surprise

−351.80%

Beats (12Q)

0/12

Next Q EPS Est

HKD 0.38

Avg Surprise (4Q)

−351.80%

Rev Surprise

2.32%

Capital & dividendView details →

Debt/Equity

0.12x

Current Ratio

2.49x

Quick Ratio

2.46x

Div Yield

0.36%

Div Rate

HKD 0.14

Div Growth 1Y

−55.41%

Financials snapshotView financials →

Revenue (TTM)

7.28B

Net Income (TTM)

93.15M

Op. CF (TTM)

1.42B

Next earningsOct 22, 2026 →

Latest newsMore news →

Tigermed reported a net loss of 413 million yuan attributable to shareholders for the first half of 2026, swinging from a profit of 383 million yuan a year earlier, while revenue grew 14.06% year-on-year to 3.708 billion yuan.7d ago

Similar companies

Illumina, Inc.ILMN 昭衍新药603127.SH Mettler-Toledo International Inc.MTD Waters CorporationWAT Quest Diagnostics IncorporatedDGX IDEXX Laboratories, Inc.IDXX Find similar companies →

Latest newsMore news →

Tigermed reported a net loss of 413 million yuan attributable to shareholders for the first half of 2026, swinging from a profit of 383 million yuan a year earlier, while revenue grew 14.06% year-on-year to 3.708 billion yuan.7d ago